Breakthrough lung cancer drug made available on NHS



A last-chance drug that can lead to an "unprecedented" reduction in lung cancer tumours is now available on the NHS.
Tagrisso (osimertinib) was granted a licence only in February and has been hailed as a "breakthrough" drug by manufacturer AstraZeneca.
The once-a-day tablet is suitable for patients with non-small-cell lung cancer who have a specific mutation that means they have stopped responding to earlier treatments.
Experts predict around 300 patients in England and Wales will be eligible for Tagrisso every year.
The National Institute for Health and Care Excellence... read more

 
4 October 2016 in Regional East, Views: 39
Source: Belper News
Share:
  •  





    News Widget for Webmasters



    Bring Eugene's son back home immediately

    Realtime News

     

    «
    »
    Mo Tu We Th Fr Sa Su
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31